Peripheral/JJ
T/NN
lymphocytes/NNS
from/IN
women/NNS
with/IN
breast/NN
cancer/NN
exhibit/VBP
abnormal/JJ
protein/NN
expression/NN
of/IN
several/JJ
signaling/VBG
molecules/NNS
./.

We/PRP
examined/VBD
signaling/VBG
molecules/NNS
of/IN
peripheral/JJ
blood/NN
T/NN
lymphocytes/NNS
obtained/VBN
from/IN
women/NNS
with/IN
breast/NN
cancer/NN
./.
=====
In/IN
6/CD
of/IN
14/CD
patients/NNS
,/,
T/NN
lymphocytes/NNS
displayed/VBD
an/DT
impaired/JJ
ability/NN
to/TO
translocate/VB
NFeB/NN
p65/NN
(/(
Rel-A/NN
)/)
following/VBG
activation/NN
by/IN
anti-CD3/NN
and/CC
IL-2/NN
./.
=====
This/DT
observation/NN
was/VBD
made/VBN
despite/IN
normal/JJ
cytoplasmic/JJ
levels/NNS
of/IN
the/DT
Rel-A/NN
protein/NN
./.
=====
We/PRP
also/RB
detected/VBD
abnormally/RB
low/JJ
levels/NNS
of/IN
the/DT
signaling/VBG
molecules/NNS
T-cell/NN
receptor/NN
(/(
TCR/NN
)/)
-zeta/NN
,/,
ZAP-70/NN
and/CC
p56lck/NN
in/IN
4/CD
of/IN
14/CD
breast/NN
cancer/NN
patients/NNS
,/,
i.e./FW
,/,
defects/NNS
in/IN
T-cell/NN
signaling/VBG
molecules/NNS
./.
=====
T/NN
lymphocytes/NNS
from/IN
6/CD
of/IN
the/DT
14/CD
patients/NNS
also/RB
exhibited/VBD
an/DT
increased/VBN
expression/NN
of/IN
the/DT
dual/JJ
specificity/NN
phosphatase/NN
,/,
map/NN
kinase/NN
phosphatase-1/NN
(/(
MKP-1/NN
)/)
./.
=====
MKP-1/NN
inactivates/VBZ
MAP/NN
kinase/NN
and/CC
therefore/RB
may/MD
interfere/VB
with/IN
the/DT
activation/NN
of/IN
c-jun/NN
and/CC
c-fos/NN
./.
=====
Abnormalities/NNS
of/IN
I/CD
or/CC
more/RBR
signaling/VBG
molecules/NNS
were/VBD
found/VBN
in/IN
9/CD
of/IN
14/CD
patients/NNS
;/:
however/RB
,/,
only/RB
3/CD
patients/NNS
had/VBD
T/NN
cells/NNS
that/WDT
exhibited/VBD
all/DT
5/CD
defects/NNS
./.
=====
Our/PRP$
data/NNS
have/VBP
implications/NNS
for/IN
the/DT
detection/NN
of/IN
potentially/RB
dysfunctional/JJ
T/NN
cells/NNS
in/IN
patients/NNS
with/IN
cancer/NN
./.
=====
For/IN
example/NN
,/,
the/DT
analysis/NN
of/IN
only/RB
1/CD
signaling/VBG
molecule/NN
may/MD
allow/VB
patients/NNS
with/IN
significant/JJ
defects/NNS
in/IN
T-cell/NN
signaling/NN
to/TO
go/VB
unnoticed/JJ
./.
=====
Finally/RB
,/,
despite/IN
impaired/JJ
Rel-A/NN
translocation/NN
,/,
T/NN
cells/NNS
were/VBD
capable/JJ
of/IN
transcribing/VBG
IL-2/NN
./.
=====
Impairments/NNS
in/IN
the/DT
translocation/NN
of/IN
Rel-B/NN
and/CC
c-Rel/NN
further/RB
suggest/VBP
that/IN
the/DT
NFKB/NN
family/NN
members/NNS
Rel-A/NN
,/,
Rel-B/NN
and/CC
c-Rel/NN
are/VBP
not/RB
required/VBN
for/IN
the/DT
transcription/NN
of/IN
IL-2/NN
in/IN
the/DT
peripheral/JJ
T/NN
lymphocytes/NNS
of/IN
patients/NNS
with/IN
breast/NN
cancer/NN
./.